The safety of antiviral therapy and drug withdrawal for the prevention of mother-to-child transmission of HBV during pregnancy

被引:13
|
作者
Xiao, Li-Xin [1 ]
Chen, Yi-Ru [2 ]
Huang, Ping [3 ]
Mei, Yong-Yu [1 ]
Pan, Calvin Q. [4 ,5 ]
Lin, Chao-Shuang [1 ]
机构
[1] Sun Yat Sen Univ, Dept Infect Dis, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Gastroenterol & Hepatol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[3] Peoples Hosp Lianjiang, Dept Infect Dis, Lianjiang, Guangdong, Peoples R China
[4] Capital Med Univ, Beijing Ditan Hosp, Ctr Liver Dis, Dept Med, Beijing, Peoples R China
[5] NYU, Dept Med, Div Gastroenterol & Hepatol, Langone Hlth,Sch Med, 132-21 41 Ave, New York, NY 11355 USA
关键词
antiviral therapy; drug withdrawal; hepatitis B virus; mother-to-child transmission; HEPATITIS-B-VIRUS; REDUCES PERINATAL TRANSMISSION; TENOFOVIR DISOPROXIL FUMARATE; SURFACE-ANTIGEN; INFECTION; EFFICACY; TELBIVUDINE; FLARES; WOMEN; PREDICTORS;
D O I
10.1002/jmv.26011
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The efficacy of prenatal antiviral therapy (AVT) for preventing the vertical transmission of hepatitis B virus (HBV) is well demonstrated. However, data are limited regarding the safety of postpartum cessation of AVT, which may induce alanine aminotransferase (ALT) elevation. We aimed to investigate the necessity of prolonging maternal AVT after delivery. Chronic hepatitis B mothers at the immune-tolerant phase with HBV DNA levels >6 log(10) IU/mL were prospectively enrolled and received AVT during the third trimester until delivery. Patients were offered to discontinue AVT either at delivery or postpartum week (PPW) 6. In addition, mothers who deferred AVT during pregnancy served as the control group. All mothers were followed until PPW 52 for clinical and virological parameters of hepatitis flares. Among 118 mothers recruited, 91 received AVT with 53 (group A) and 24 (group B) discontinue their treatment at delivery and PPW 6, respectively. Twenty-seven mothers who deferred AVT during pregnancy were followed as the control (group C). A total of 104 of 118 mothers who completed the study, 50% (52/104) had postpartum-elevated ALT levels, which were mild and moderate except 6 of 104 (5.77%) of patients had levels >= 5 times the upper limit of normal; 70% (36/52) of the ALT flares occurred within 12 weeks after delivery. In subgroup analyses, the frequency of ALT elevation was similar among the groups A vs B vs C (50.9% [27/53] vs 58.3% [14/24] vs 40.7% [11/27], respectively;P = .447), as well as the mean peak ALT level (108.4/74.1/126.7 U/L in groups A/B/C, respectively;P = .291). Although postpartum ALT flares were common for mothers with or without AVT during pregnancy, most cases of ALT elevation were mild to moderate. Our study observed that extending AVT to PPW 6 did not affect maternal outcomes and ATV should be discontinued at birth. Close monitoring is warranted as severe flares rarely occurred.
引用
收藏
页码:3381 / 3389
页数:9
相关论文
共 50 条
  • [31] THE EFFICACY AND SAFETY OF TELBIVUDINE OR TENOFOVIR DISOPROXIL IN PREGNANCY FOR PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HEPATITIS B VIRUS
    Huang, H.
    Zhang, Y.
    Wu, Q.
    Wang, Y.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S560 - S560
  • [32] The efficacy of Telbivudine used in entire pregnancy course in blocking mother-to-child HBV transmission
    Yi, Wei
    Xie, Yao
    Hu, Yu-Hong
    Li, Ming-hui
    HEPATOLOGY, 2014, 60 : 1004A - 1005A
  • [33] Vaccines for prevention of mother-to-child transmission of HIV
    Cunningham, Coleen K.
    McFarland, Elizabeth
    CURRENT OPINION IN HIV AND AIDS, 2008, 3 (02) : 151 - 154
  • [34] Timing and prevention: mother-to-child transmission of HIV
    不详
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2006, 96 (12): : 1244 - 1244
  • [35] Prevention of mother-to-child transmission of HIV in Haiti
    Deschamps, Marie-Marcelle
    Noel, Francine
    Bonhomme, Jerry
    Devieux, Jessy G.
    Saint-Jean, Gilbert
    Zhu, Yuwei
    Wright, Peter
    Pape, Jean W.
    Malow, Robert M.
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2009, 25 (01): : 24 - 30
  • [36] Prevention and treatment of mother-to-child transmission of syphilis
    Braccio, Serena
    Sharland, Mike
    Ladhani, Shamez N.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2016, 29 (03) : 268 - 274
  • [37] ART in Prevention of Mother-to-Child Transmission of HIV
    Abhilasha Gupta
    Aruna Verma
    Monika Kashyap
    Priti Gautam
    The Journal of Obstetrics and Gynecology of India, 2020, 70 : 18 - 22
  • [38] Prevention of mother-to-child HIV transmission internationally
    Shaffer, N
    McConnell, M
    Bolu, O
    Mbori-Ngacha, D
    Creek, T
    Ntumy, R
    Mazhani, L
    EMERGING INFECTIOUS DISEASES, 2004, 10 (11) : 2027 - 2028
  • [39] Prevention of mother-to-child transmission of HIV infection
    Thorne, C
    Newell, ML
    CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (03) : 247 - 252
  • [40] Strategies for prevention of mother-to-child transmission of HIV
    Luo, CW
    REPRODUCTIVE HEALTH MATTERS, 2000, 8 (16) : 144 - 155